Research Analysts’ Weekly Ratings Updates for The Ensign Group (ENSG)

Several analysts have recently updated their ratings and price targets for The Ensign Group (NASDAQ: ENSG):

• 2/9/2026 – The Ensign Group had its “outperform” rating reaffirmed by Royal Bank Of Canada. They now have a $222.00 price target on the stock, up from $206.00.
• 2/7/2026 – The Ensign Group was upgraded by Wall Street Zen from “hold” to “buy”.
• 2/6/2026 – The Ensign Group was given a new $215.00 price target by Truist Financial Corporation. They now have a “hold” rating on the stock.
• 2/6/2026 – The Ensign Group was given a new $230.00 price target by UBS Group AG. They now have a “buy” rating on the stock.
• 1/22/2026 – The Ensign Group had its “buy (b)” rating reaffirmed by Weiss Ratings.

The Ensign Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Saturday, January 31st. Stockholders of record on Wednesday, December 31st were paid a $0.065 dividend. This represents a $0.26 annualized dividend and a dividend yield of 0.1%. The ex-dividend date was Wednesday, December 31st. This is a boost from The Ensign Group’s previous quarterly dividend of $0.06. The Ensign Group’s dividend payout ratio (DPR) is 4.45%.

Insider Buying and Selling at The Ensign Group

In related news, VP Beverly B. Wittekind sold 8,400 shares of The Ensign Group stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $175.48, for a total value of $1,474,032.00. Following the completion of the transaction, the vice president owned 32,779 shares in the company, valued at $5,752,058.92. The trade was a 20.40% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John O. Agwunobi sold 246 shares of the business’s stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an average price of $179.82, for a total transaction of $44,235.72. Following the transaction, the director owned 9,233 shares of the company’s stock, valued at $1,660,278.06. This trade represents a 2.60% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 27,473 shares of company stock valued at $5,147,297. 3.90% of the stock is currently owned by company insiders.

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.